Muscarinic Acetylcholine Receptor M2/CHRM2 Antibody (31-1D1)

Immunohistochemistry-Paraffin: Muscarinic Acetylcholine Receptor M2/CHRM2 Antibody (31-1D1) [NB120-2805]

Immunohistochemistry-Paraffin: Muscarinic Acetylcholine Receptor M2/CHRM2 Antibody (31-1D1) [NB120-2805] - Human kidney tissue.

Western Blot: Muscarinic Acetylcholine Receptor M2/CHRM2 Antibody (31-1D1) [NB120-2805] -

Purinergic and muscarinic signaling associated molecules changes on western blot study in separated group. Figure 7 showed the expression of muscarinic cholinergic (M2 and M3) and purinergic receptor proteins (P2X2 and P2X3) by Western blot. In the top panel, (a) showed the expression of M2 receptor is significantly decreased in BPAO + ADSCs group compared to BAPO group (# p < 0.05). The expression of M2 receptor had trend of decreasing in BPAO + ADSC-derived MVs group compared to BAPO group without significant differences (p > 0.05). In the middle panel, (b) showed that the expression of M3 receptor was significantly increased in BPAO group compared to sham group (* p < 0.05). The expression of M3 receptor is significantly decreased in BPAO + ADSC-derived MVs group compared to BAPO group (# p < 0.05). (c) showed the expression of P2X2 receptors was significantly increased in BPAO group compared to sham group (* p < 0.05). The expression of P2X2 receptor is significantly decreased in BPAO + ADSC-derived MVs and BAPO + MVs group compared to BAPO group (#p < 0.05). In the bottom panel, (d) showed the expression of P2X3 receptor is of no significant differences between groups. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34210091), licensed under a CC-BY license. Not internally tested by Novus Biologicals.